A diverse and intricate array of substances is increasingly being detected in the illicit drug scene in Calgary, with a surge in overdoses prompting swift responses from various frontline organizations in the city.
Recent investigations by the University of Calgary have uncovered samples in the past three months containing over 11 different substances, including mixes of fentanyl, carfentanil, methamphetamines, ketamine, and other potent opioids or tranquilizers. Dr. Monty Ghosh, a researcher at the university, emphasized the concerning lack of consistency among the samples, making it challenging to predict the effects of the substances consumed.
The evolving drug landscape poses significant risks, as individuals who overdose on this cocktail of substances may be harder to revive. While naloxone can counter opioid overdoses, it may not be as effective against compounds blended with tranquilizers or benzodiazepines.
According to Ghosh, the constantly shifting and unpredictable nature of the samples underscores the volatility of the situation. This unpredictability has led to a notable increase in reported overdoses across Calgary, with organizations such as the Calgary Drop-In Centre witnessing a surge in cases compared to previous years.
The drop-in center’s chief operating officer, David Sawatzky, expressed alarm at surpassing the previous year’s overdose count by mid-April. The center has noted a rise in the presence of the veterinary-grade tranquilizer medetomidine in samples, heightening concerns among clients about the safety of the drug supply.
The prevalence of a more toxic substance mix has heightened anxiety among drug users, as they have limited control over the substances they consume. The increased frequency of overdoses has strained resources, with frontline agencies like the Calgary Drop-In Centre and Alpha House facing the challenge of managing multiple drug poisonings daily.
The escalating crisis has also been reflected in emergency response data, with a notable uptick in opioid-related incidents and substance-related emergencies in Calgary. The presence of medetomidine, a tranquilizer intended for animal use, has been detected more frequently not only in Alberta but also in cities like Toronto and Winnipeg.
While the province has seen a decline in opioid-related overdose deaths, the emergence of a democratized drug manufacturing landscape has complicated the situation. Ghosh highlighted the accessibility of precursor substances globally, allowing individuals to create and distribute drugs more easily, leading to a more diverse and hazardous drug supply.
To address the evolving challenges, Ghosh advocated for an early alert system to notify drug users and healthcare providers about shifts in the drug supply promptly. He stressed the importance of supervised consumption sites in responding effectively to overdoses, underscoring the need for proactive measures to mitigate the risks posed by the unpredictable drug market.
Despite recent stabilization in overdose figures at some shelters, researchers remain vigilant about the potential for rapid changes in the drug supply to disrupt progress. The ongoing vigilance and collaboration among stakeholders are crucial to safeguarding public health in the face of a dynamic and volatile drug landscape.
